TRISTAN study: lung imaging in drug safety assessment 26th February 2018

This month we recruited the first UK patient to a study investigating MRI imaging methods in lung disease. The study will recruit people with drug-induced interstitial lung disease and is part of an EU Horizon 2020 funded programme (TRISTAN - Translational Imaging in Drug Safety Assessment) to develop new imaging methods and speed up drug development. The University of Sheffield POLARIS Group is the study’s UK imaging centre. For further details please contact Dr James Eaden, j.a.eaden@sheffield.ac.uk 

For further info see https://www.sheffield.ac.uk/iicd/news/new-tristan_project_leverages_potential_of_imaging_techniques_in_drug_safety_assessment-1.695490